Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer

Por Marmorino, Federica, Salvatore, Lisa, Barbara, Cecilia, Allegrini, Giacomo, Antonuzzo, Lorenzo, Masi, Gianluca, Loupakis, Fotios, Borelli, Beatrice, Chiara, Silvana, Banzi, Maria Chiara, Miraglio, Emanuela, Amoroso, Domenico, Dargenio, Francesco, Bonetti, Andrea, Martignetti, Angelo, Paris, Myriam, Tomcikova, Daniela, Boni, Luca, Falcone, Alfredo, Cremolini, Chiara
Publicado no Br J Cancer (2017)

Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer

Por Moretto, Roberto, Cremolini, Chiara, Rossini, Daniele, Pietrantonio, Filippo, Battaglin, Francesca, Mennitto, Alessia, Bergamo, Francesca, Loupakis, Fotios, Marmorino, Federica, Berenato, Rosa, Marsico, Valentina Angela, Caporale, Marta, Antoniotti, Carlotta, Masi, Gianluca, Salvatore, Lisa, Borelli, Beatrice, Fontanini, Gabriella, Lonardi, Sara, De Braud, Filippo, Falcone, Alfredo
Publicado no Oncologist (2016)

Single-Agent Panitumumab in Frail Elderly Patients With Advanced RAS and BRAF Wild-Type Colorectal Cancer: Challenging Drug Label to Light Up New Hope

Por Pietrantonio, Filippo, Cremolini, Chiara, Aprile, Giuseppe, Lonardi, Sara, Orlandi, Armando, Mennitto, Alessia, Berenato, Rosa, Antoniotti, Carlotta, Casagrande, Mariaelena, Marsico, Valentina, Marmorino, Federica, Cardellino, Giovanni Gerardo, Bergamo, Francesca, Tomasello, Gianluca, Formica, Vincenzo, Longarini, Raffaella, Giommoni, Elisa, Caporale, Marta, Di Bartolomeo, Maria, Loupakis, Fotios, de Braud, Filippo
Publicado no Oncologist (2015)